ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

Ann Thorac Surg 1996;62:1730
© 1996 The Society of Thoracic Surgeons

Discussion

Discussion

The first 20% of the full text of this article appears below.

see also page 1724.

DR YARON BAR-EL (Haifa, Israel): I congratulate Dr Gabbay and his group for this excellent research and presentation. After a careful review of the preclinical data, we at the Rambam Medical Center in Israel have joined a few European and South American clinical centers to investigate the No-React bioprosthesis. We have been using the No-React bioprosthesis for the past year and have implanted various kinds of grafts in 8 patients. We have implanted two stentless mitral valves, five aortic stentless valves, one porcine internal mammary artery graft, and one femoropopliteal bypass below-knee graft using a bovine internal mammary artery graft. I would like to draw your attention to 2 patients who were youngsters, aged 12 and 13 years, at the time of operation.

The first is a girl who was flown in emergently with active bacterial endocarditis that destroyed her mitral . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1996 by The Society of Thoracic Surgeons.